Identification of Optimal Donor-Recipient Combinations Among Human Immunodeficiency Virus (HIV)-Positive Kidney Transplant Recipients

被引:8
|
作者
Locke, J. E. [1 ]
Shelton, B. A. [1 ]
Reed, R. D. [1 ]
MacLennan, P. A. [1 ]
Mehta, S. [1 ]
Sawinski, D. [2 ]
Segev, D. L. [3 ]
机构
[1] Univ Alabama Birmingham, Comprehens Transplant Inst, Birmingham, AL 35233 USA
[2] Univ Penn, Comprehens Transplant Ctr, Philadelphia, PA 19104 USA
[3] Johns Hopkins Univ, Baltimore, MD USA
基金
美国国家卫生研究院;
关键词
clinical research; practice; health services and outcomes research; infectious disease; kidney transplantation; nephrology; immune deficiency; infection and infectious agents; viral: human immunodeficiency virus (HIV); acquired immunodeficiency syndrome (AIDS); viral: hepatitis C; RENAL-TRANSPLANTATION; ACUTE REJECTION; HIV; IMMUNOSUPPRESSION; SURVIVAL; OUTCOMES; LIVER;
D O I
10.1111/ajt.13847
中图分类号
R61 [外科手术学];
学科分类号
摘要
For some patient subgroups, human immunodeficiency virus (HIV) infection has been associated with worse outcomes after kidney transplantation (KT); potentially modifiable factors may be responsible. The study goal was to identify factors that predict a higher risk of graft loss among HIV-positive KT recipients compared with a similar transplant among HIV-negative recipients. In this study, 82 762 deceased donor KT recipients (HIV positive: 526; HIV negative: 82 236) reported to the Scientific Registry of Transplant Recipients (SRTR) (2001-2013) were studied by interaction term analysis. Compared to HIV-negative recipients, the hepatitis C virus (HCV) amplified risk 2.72-fold among HIV-positive KT recipients (adjusted hazard ratio [aHR]: 2.72, 95% confidence interval [CI]: 1.75-4.22, p < 0.001). Forty-three percent of the excess risk was attributable to the interaction between HIV and HCV (attributable proportion of risk due to the interaction [AP]: 0.43, 95% CI: 0.23-0.63, p = 0.02). Among HIV-positive recipients with more than three HLA mismatches (MMs), risk was amplified 1.80-fold compared to HIV-negative (aHR: 1.80, 95% CI: 1.31-2.47, p < 0.001); 42% of the excess risk was attributable to the interaction between HIV and more than three HLA MMs (AP: 0.42, 95% CI: 0.24-0.60, p = 0.01). High-HIV-risk (HIV-positive/HCV-positive HLAwith more than three MMs) recipients had a 3.86-fold increased risk compared to low-HIV-risk (HIV-positive/HCV-negative HLA with three or fewer MMs)) recipients (aHR: 3.86, 95% CI: 2.37-6.30, p < 0.001). Avoidance of more than three HLA MMs in HIV-positive KT recipients, particularly among coinfected patients, may mitigate the increased risk of graft loss associated with HIV infection. Avoidance of HLA mismatches in HIV-infected kidney transplant recipients, particularly among those coinfected with hepatitis C, may mitigate the increased risk of graft loss associated with HIV infection.
引用
收藏
页码:2377 / 2383
页数:7
相关论文
共 39 条
  • [21] Human immunodeficiency virus from life taking to life giving: expanding the donor pool by using HIV-positive donors
    Mehta, Shikha
    Locke, Jayme E.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2020, 25 (06) : 626 - 630
  • [22] Choice of induction regimens on the risk of cytomegalovirus infection in donor-positive and recipient-negative kidney transplant recipients
    Luan, F. L.
    Samaniego, M.
    Kommareddi, M.
    Park, J. M.
    Ojo, A. O.
    TRANSPLANT INFECTIOUS DISEASE, 2010, 12 (06) : 473 - 479
  • [23] Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients
    Sampaio, Marcelo Santos
    Cho, Yong W.
    Shah, Tariq
    Bunnapradist, Suphamai
    Hutchinson, Ian V.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (07) : 2971 - 2979
  • [24] Altered Immune Reconstitution in Allogeneic Stem Cell Transplant Recipients With Human Immunodeficiency Virus (HIV)
    Murray, Daniel D.
    Zaunders, John
    Milliken, Samuel T.
    Munier, C. Mee Ling
    Ford, Carole
    Morrissey, C. Orla
    Visweswaran, Malini
    Avery, Sharon
    Sasadeusz, Joseph
    Kwan, John
    Desai, Shrinivas
    Law, Matthew
    Koelsch, Kersten K.
    Lewin, Sharon R.
    Moore, John
    Kelleher, Anthony D.
    Polizzotto, Mark N.
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (07) : 1141 - 1146
  • [25] The first report of kidney transplantation in a human immunodeficiency virus-positive recipient in Thailand and literature review: Encouragement for developing countries in Southeast Asia
    Udomkarnjananun, Suwasin
    Naiyarakseree, Nuanjanthip
    Townamchai, Natavudh
    Surinrat, Ekkapong
    Tiankanon, Kanitha
    Banjongjit, Athiphat
    Vanichanan, Jakapat
    Jutivorakool, Kamonwan
    Putcharoen, Opass
    Suankratay, Chusana
    Surintrspanont, Jerasit
    Iampenkhae, Kroonpong
    Leelahavanichkul, Asada
    Wattanatorn, Salin
    Apisutimaitri, Kirada
    Burimsittichai, Rattanaporn
    Ratchanon, Supoj
    Nonthasoot, Bunthoon
    Sirichindakul, Boonchoo
    Praditpornsilpa, Kearkiat
    Avihingsanon, Yingyos
    SAGE OPEN MEDICAL CASE REPORTS, 2021, 9
  • [26] Simultaneous Pancreas-Kidney Transplantation in a Human Immunodeficiency Virus-Positive Recipient: A Case Report
    Genzini, T.
    Noujaim, H. M.
    Mota, L. T.
    Crescentini, F.
    Antunes, I.
    Di Jura, V. L.
    Ferreira, F. A. Y.
    Muller, B. F.
    Vetorazzo, J. E.
    de Miranda, M. P.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (02) : 591 - 593
  • [27] Preemptive anti-cytomegalovirus therapy in high-risk (donor-positive, recipient-negative cytomegalovirus serostatus) kidney transplant recipients
    Hasegawa, Jumpei
    Hatakeyama, Shuji
    Wakai, Sachiko
    Omoto, Kazuya
    Okumi, Masayoshi
    Tanabe, Kazunari
    Mieno, Makiko
    Shirakawa, Hiroki
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 65 : 50 - 56
  • [28] Tacrolimus toxicity management in a pregnant kidney transplant recipient with newly diagnosed human immunodeficiency virus: A case report
    Matarneh, Ahmad
    Chokshi, Ravi
    Sardar, Sundus
    Salmeron, Dinia
    O'brien, James
    Khalil, Fareeha
    Trivedi, Naman
    Ghahramani, Nasrollah
    Shah, Vaqar
    SAGE OPEN MEDICAL CASE REPORTS, 2025, 13
  • [29] Southern African HIV Clinicians Society guidelines for solid organ transplantation in human immunodeficiency virus: An evidence-based framework for human immunodeficiency virus-positive donors and recipients
    Nel, Jeremy S.
    Conradie, Francesca
    Botha, Jean
    Etheredge, Harriet
    Fabian, June
    Levin, Leon
    Mazanderani, Ahmad H.
    Moorhouse, Michelle
    Muller, Elmi
    Tiemessen, Caroline
    Thomson, David
    Turner, Julia
    SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 2020, 21 (01)
  • [30] Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis
    Stevens, D. R.
    Sawinski, D.
    Blumberg, E.
    Galanakis, N.
    Bloom, R. D.
    Trofe-Clark, J.
    TRANSPLANT INFECTIOUS DISEASE, 2015, 17 (02) : 163 - 173